IP Library Granted Patent US 10,844,033
Granted Patent B2
US 10,844,033 · App. 16/095,512 · Granted Nov 24, 2020

Method for preparing delta-lactones

Inventors: Sarim Dastgir (Doha, QA); Badria Al-Shihi (Muscat, OM); Mohammad Sharif (Rostock, DE); Matthias Beller (Rostock, DE); Ralf Jackstell (Rostock, DE)
Assignees: Qatar Found. For Ed., Science and Community Development; Sultan Qaboos University; Leibniz-Institut Fur Katalyse e.V. an der Unversitat Rostock
C07D309/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,844,033
App. No.
16/095,512
Granted
Nov 24, 2020
Kind
B2
Abstract

The present invention relates to methods of forming delta-lactone compounds by reaction of a diene with carbon dioxide in the presence of Pd and a phosphine ligand.

Claims (27)

1. A method of forming a compound of formula (I):

the method comprising the steps of:

(i) providing a compound of the formula (II), (III) or (IV):

wherein,

R 1 is H, unsubstituted alkyl, substituted alkyl, unsubstituted phenyl or substituted phenyl;

R 2 is H, unsubstituted alkyl, substituted alkyl, unsubstituted phenyl or substituted phenyl;

R 3 is H;

R 4 is H, unsubstituted alkyl, substituted alkyl, unsubstituted phenyl or substituted phenyl; and,

(ii) reacting the compound of formula (II), (III) or (IV) with CO 2 in the presence of a source of Pd(0) and a phosphine ligand to form the compound of formula (I), wherein the phosphine ligand is any one of:

P(2-OMe-Ph) 3 , P(2-furyl) 3 ,

wherein Ph is —C 6 H 5 , Cy is —C 6 H 11 , Me is —CH 3 and Ad is adamantyl.

2. The method of claim 1 , wherein the term substituted refers to the particular moiety substituted with 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 substituents selected from the group consisting of H, alkyl, aryl, alkenyl, alkynyl, arylalkyl, alkoxy, aryloxy, arylalkoxy, alkoxyalkylaryl, alkylamino, arylamino, 2-OMe-Ph, phenyl, 2-furyl, NH 2 , OH, CN, NO 2 , OCF 3 , CF 3 , Br, Cl, F, 1-amidino, 2-amidino, alkylcarbonyl, morpholino, piperidinyl, dioxanyl, pyranyl, heteroaryl, furanyl, thiophenyl, tetrazolo, thiazole, isothiazolo, imidazolo, thiadiazole, thiadiazole S-oxide, thiadiazole S,S-dioxide, pyrazolo, oxazole, isoxazole, pyridinyl, pyrimidinyl, quinoline, isoquinoline, SR′″, SOR′″, SO 2 R′″, CO 2 R′″, COR′″, CONR′″R′″, CSNR′″R′″ and SO n NR′″R′″, wherein R′″ is alkyl or substituted alkyl.

3. The method of claim 1 , wherein the source of Pd(0) is selected from the group consisting of Pd(acac) 2 , Pd(OAc) 2 , PdCl 2 (MeCN) 2 , Pd(dba) 2 , [PdCl(allyl)] 2 , Pd 2 (dba) 3 , and a Pd(II) complex that can be reduced in situ to produce Pd(0) species.

4. The method of claim 1 , wherein R 1 , R 2 , R 3 and R 4 are each H.

5. The method of claim 1 , wherein the step of providing a compound of formula (I) includes providing 1,3-butadiene

6. The method of claim 1 , wherein the method is a method of forming δ-lactone, namely,

7. The method of claim 1 , wherein the step of reacting the compound of formula (II), (III) or (IV) with CO 2 in the presence of the source of Pd(0) and the phosphine ligand to form the compound of formula (I) takes place in a solvent.

8. The method of claim 7 , wherein the solvent is MeCN, propylene carbonate or ethylene carbonate.

9. The method of claim 1 , wherein the step of reacting the compound of formula (II), (III) or (IV) with CO 2 in the presence of the source of Pd(0) and the phosphine ligand to form the compound of formula (I) utilises CO 2 as a reactant in gaseous form.

10. The method of claim 1 , wherein the method is a method of forming δ-lactone, namely,

the method comprising the steps of:

(i) providing 1,3-butadiene

 and,

(ii) reacting 1,3-butadiene

 with CO 2 in the presence of the source of Pd(0) and the phosphine ligand to form δ-lactone.

11. The method of claim 1 , wherein the source of Pd(0) is Pd(acac) 2 .

12. The method of claim 1 , wherein the phosphine ligand is P(2-OMe-Ph) 3 (TOMP; tris(2-methoxyphenyl)phosphine).

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2025
From: QATAR FOUNDATION FOR EDUCATION, SCIENCE & COMMUNITY DEVELOPMENT
To: HAMAD BIN KHALIFA UNIVERSITY
Reel/Frame 069936/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2018
From: DASTGIR, SARIM
To: QATAR FOUNDATION FOR EDUCATION, SCIENCE AND COMMUNITY DEVELOPMENT
Reel/Frame 047498/0441 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2018
From: AL-SHIHI, BADRIA
To: SULTAN QABOOS UNIVERSITY
Reel/Frame 047498/0878 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2018
From: SHARIF, MUHAMMAD; BELLER, MATTHIAS; JACKSTELL, RALF
To: LEIBNIZ-INSTITUT FÜR KATALYSE E.V. AN DER UNIVERSITÄT ROSTOCK
Reel/Frame 047499/0331 →
Priority Claims (1)
GB 1609314.8 · May 26, 2016 · national
Continuity (1)
Related Publication 20190127343A1 · May 2, 2019